ANI PHARMACEUTICALS, INC Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
ANI PHARMACEUTICALS, INC (ANIP) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $11.53 million as of 2011-06-30, per its 10-Q filed 2011-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2011-08-05
- 2011-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $11.53M.
- 2010-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $19.15M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2011-06-30 | $11.53M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $19.15M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |